Related Experiment Video
Updated: Jun 10, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Toxicological insights into formaldehyde-induced copd: a study on gene expression and molecular interactions
Sana Waheed1, Adnan Afzal2, Saima Ejaz3
1Department of Biochemistry, University of Agriculture Faisalabad, Faisalabad, Pakistan.
Cytotechnology
|June 9, 2026
Summary
Formaldehyde exposure damages lung tissue and downregulates SFTPD and GSTα4 gene expression, contributing to chronic obstructive pulmonary disease (COPD). These genes show promise as biomarkers for COPD diagnosis and prognosis.
Area of Science:
- Environmental Health
- Toxicology
- Pulmonary Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) is a significant respiratory illness often exacerbated by environmental factors like air pollutants and chemical products.
- Understanding the molecular mechanisms underlying COPD pathogenesis is crucial for developing effective diagnostic and therapeutic strategies.
Purpose of the Study:
- To investigate the toxic effects of formaldehyde on lung tissue and gene expression in a mouse model.
- To evaluate the potential of SFTPD and GSTα4 genes as diagnostic and prognostic biomarkers for formaldehyde-induced COPD.
Main Methods:
- Development of a formaldehyde-induced COPD mouse model.
- Intraperitoneal administration of varying formaldehyde doses.
- Determination of SFTPD and GSTα4 gene expression via molecular assays.
- Histopathological examination of lung tissues.
- In silico analysis including ADMET and molecular docking.
Main Results:
- Formaldehyde administration led to significant lung tissue damage consistent with COPD pathology.
- A dose-dependent downregulation of SFTPD and GSTα4 gene expression was observed in formaldehyde-exposed mice.
- In silico analyses suggested formaldehyde interaction with SFTPD and GSTα4 may impair lung function.
- ADMET analysis revealed formaldehyde's pharmacokinetic properties and potential toxicities.
Conclusions:
- Formaldehyde exposure induces COPD-like pathology and alters the expression of key lung genes.
- SFTPD and GSTα4 show potential as valuable biomarkers for diagnosing and predicting the progression of COPD.
- This study provides insights into formaldehyde's respiratory toxicity and its role in COPD pathogenesis.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.